New Search

If you are not happy with the results below please do another search

Search
Generic filters

50 search results for:

21

J&J wins FDA nod for pulmonary arterial hypertension combo pill

The combo pill is indicated for chronic use in pulmonary arterial hypertension (PAH) patients falling under the World Health Organization’s functional classes II to III. These classes include patients who may have no symptoms at rest but experience shortness of breath or discomfort during normal activities such as climbing stairs or running errands.

23

EVERSANA and MyHealthTeam launch groundbreaking direct-to-patient solution to accelerate time to diagnosis and treatment

The new offering will help life science and pharmaceutical brands create better and more personalized experiences for both diagnosed and undiagnosed patient populations, accelerating paths to diagnosis and treatment, and creating unmatched educational opportunities. Brand teams will gain unmatched insights into what patient communities are saying and looking for, and then serve up customized content to help them at any stage of the patient journey.